Periodontal Disease and Lipid Metabolism Interactions

Periodontal disease, a chronic inflammatory condition affecting the supporting structures of the teeth, has emerged as a significant modulator of systemic lipid metabolism. Persistent infection in the gingival tissues provokes a host immune response that extends beyond the oral cavity, promoting dysregulation of lipoprotein profiles and oxidative stress. Altered levels of low-density lipoprotein (LDL), high-density lipoprotein (HDL) and triglycerides create a feedback loop in which systemic lipid abnormalities exacerbate periodontal breakdown, while periodontal inflammation further impairs lipid function. This bidirectional interplay carries global importance, linking oral health to cardiovascular disease risk and supporting integrated approaches to the prevention and management of non-communicable conditions. Practical applications include the use of lipid ratios as markers of periodontal risk and the potential for periodontal therapy to improve lipoprotein quality.

Research from Nature Portfolio

Recent analyses of nationally representative cohorts have introduced the non-HDL to HDL cholesterol ratio as a sensitive marker of periodontal status. In a large cross-sectional study, individuals with higher ratios displayed a 7% increase in periodontitis prevalence for each unit rise, underscoring the predictive value of this lipid metric. In a separate longitudinal investigation among patients with type 2 diabetes, comprehensive periodontal debridement led to measurable improvements in the structural quality of LDL particles over 12 months, although levels of oxidised LDL remained constant. These findings illustrate that periodontal intervention can restore aspects of lipoprotein function, reinforcing the systemic benefits of oral health management.

Periodontal Disease and Lipid Metabolism Interactions publication trend

The graph below shows the total number of articles in periodontal disease and lipid metabolism interactions across all publications each year (not limited to Nature Index journals).

Technical terms

Periodontitis: Chronic inflammatory destruction of the tooth-supporting tissues, marked by periodontal pocket formation and attachment loss.

Dyslipidemia: Abnormal levels or proportions of lipids in the blood, including elevated LDL, reduced HDL or increased triglycerides.

High-density lipoprotein (HDL) cholesterol: The “protective” lipoprotein involved in reverse cholesterol transport and anti-inflammatory functions.

Low-density lipoprotein (LDL) cholesterol: The “atherogenic” lipoprotein that delivers cholesterol to tissues and may undergo oxidative modification.

Atherogenic index of plasma (AIP): A logarithmic ratio of triglycerides to HDL cholesterol, used as a marker of lipid-related cardiovascular and periodontal risk.

Non-HDL to HDL cholesterol ratio (NHHR): A lipid metric comparing all atherogenic lipoproteins to HDL, employed to predict the prevalence of periodontitis.

References

1. The Role of Dyslipidemia in Periodontitis. Nutrients (2023).
2. Causal relationship between circulating lipid traits and periodontitis: univariable and multivariable Mendelian randomization. Frontiers in Endocrinology (2023).
3. The association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) and prevalence of periodontitis among US adults: a cross-sectional NHANES study. Scientific Reports (2024).
4. Modified lipoproteins in periodontitis - a link to cardiovascular disease?. Bioscience Reports (2019).
5. Association between atherogenic index of plasma and periodontitis among U.S. adults. BMC Oral Health (2023).